FDA Logo links to FDA home page
U.S. Food and Drug Administration
  HHS Logo links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program

line line line line line

Stay Informed
Subscribe to receive safety alerts
Get e-mail updates By email | MedWatch RSS [XML] Feed By RSS

What's New

Topical Anesthetics - Patients, healthcare professionals, and caregivers alerted to serious hazards of using skin numbing products for relieving pain from mammography and other medical tests and conditions, especially when applied to a large area of skin or when the area of application is covered.
(Posted 01/16/2009)

Drug Safety Newsletter, Volume 2, Issue 1, 2009 - FDA newsletter provides information for healthcare professionals about the findings of selected post-marketing drug safety reviews, important emerging drug safety issues, and recently approved new drugs.
(Posted 01/16/2009)

Singulair (montelukast) - FDA provided updated information to its March 2008 Early Communication.
(Posted 01/13/2008)

Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor): Update of Safety Review - The FDA has completed its review of the final clinical study report of ENHANCE and issued an update.
(Posted 01/08/2009)

January 2009 Patient Safety News - Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
(Posted 01/07/2009)

Welcome to MedWatch, your Internet gateway for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration.


Safety Information

Safety Information


Medical Product

Medical Product Reporting

Educational Resources

 FDA MedWatch and Patient Safety

A self-learning tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting. MedWatch tutorial screenshots
horizonal rule